US court rejects pharma views against new patent rules
24 March 2009
Sue Sutter
A divided US appeals court has upheld several new patent prosecution rules opposed by the pharmaceutical industry, but the decision leaves the door open to further appellate review and potential invalidation of the regulations on other grounds.
The US Federal Circuit Court of Appeals reinstated...
Please Login to read the full article.
24 March 2009
Sue Sutter
The US Federal Circuit Court of Appeals reinstated...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Potential lack of standing could end Myriad case with no DNA patent resolution
- After rancorous 2011, BIO expects some congressional rematches in 2012
- US Capitol Capsule: Patent reform done, but will it create jobs?
- Pfizer's 'non obvious' Viagra patents good until 2019 to fend off Teva in US
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
